A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer
Yun Yen(City of Hope), Kim Margolin(City of Hope), James H. Doroshow(City of Hope), Mayer Fishman(Moffitt Cancer Center), Bonny Johnson(Vion Pharmaceuticals (United States)), Caroline Clairmont(Vion Pharmaceuticals (United States)), Dan M. Sullivan(Moffitt Cancer Center), Mario Sznol(Vion Pharmaceuticals (United States))
Cited by 89
Abstract
Related Papers
No related papers found
Powered by citation graph analysis